Saturday Mar 8
ABCs Guide to common cat poisonings, H-M
Many commonly used rooms have hidden hazards. Find out what to watch out for and what you can do to protect your pets.
Trending on the Topix Network
Fri Mar 07, 2014
nutritious secrets of ginger and garlic
Ginger and garlic are underground edible plant portions generally used as spice in South Asia.
Health benefits of banana
Bananas are one of the most widely consumed fruits in the world for good reason.
Santa Barbara County Animal Services is recommending the community to be on high alert after identifying cases of apparent distemper in raccoons in the Santa Barbara area.
Thu Mar 06, 2014
Napo Loses Lawsuit Against Salix Over Diarrhea Drug
Napo Pharmaceuticals has lost its lawsuit against Salix Pharmaceuticals, in which the biotech firm accused Salix of deliberately thwarting the success of Fulyzaq , the first-ever drug approved to treat diarrhea related to HIV meds.
Treating a symptom is not the same as treating a disease
Physicians and patients collaborate to treat symptoms. This is not newsworthy and even sounds appropriate.
Wed Mar 05, 2014
Norovirus Outbreak Reported at Spaulding Rehab in Charlestown
Officials at Spaulding Rehabilitation Hospital in Charlestown are battling a norovirus outbreak that has sickened 22 out of 132 inpatients and three staff members since Tuesday afternoon, Boston.com reported Wednesday .
Mon Mar 03, 2014
Actelion Ltd.'s Diarrhea Treatment Gets Fast-Track From The FDA
Actelion's novel antibiotic cadazolid receives US FDA Qualified Infectious Disease Product designation for the treatment of Clostridium difficile-associated diarrhea ALLSCHWIL/BASEL, SWITZERLAND - 27 February 2014 - Actelion Ltd today announced that the US Food and Drug Administration has designated cadazolid as both a Qualified Infectious Disease ... (more)
Sun Mar 02, 2014
REVISED* Blackburn's mother's cancer drug
Stephen Blackwood recently wrote a post in the Wall Street Journal in which he claimed that Obamacare was denying his mother of the cancer drug Sandostatin.
Thu Feb 27, 2014
Actelion diarrhea treatment gets fast-track from U.S. FDA
Actelion Ltd, Europe's biggest biotech company, said on Thursday that the U.S. health regulator has granted fast-track status to its antibiotic treatment for diarrhea.
Tue Feb 25, 2014
Local Tech Wire
Salix prevails in $150M suit filed by drug partner
In a legal fight dating to 2011, Raleigh-based Salix Pharmaceuticals has won a jury decision that throws out a lawsuit filed against it by drug partner Napo Pharmaceuticals.
Researchers Uncover the Secret Behind Bowel Movements
New research reveals that two sets of so-called "pacemakers" work together to create a certain rhythm, and these pacemakers use nerves and muscles to allow two types of movement: one that allows the body to absorb nutrients and another that moves food along the digestive tract.
Mon Feb 24, 2014
White Coat Notes: The pros of probiotics
Probiotics are bacteria and yeast microorganisms -- naturally occurring in some foods -- that offer various health benefits by keeping the beneficial microbial environment within our intestinal tract in check.
Thu Feb 13, 2014
Capitol Hill Times
The ins and outs of food poisoning
Unfortunately, there isn't a faster or less painful way to recover from food-borne illnesses.
Wed Feb 12, 2014
Laser tool speeds up detection of Salmonella in food products
Purdue University researchers have developed a laser sensor that can identify Salmonella bacteria grown from food samples about three times faster than conventional detection methods.
Centers for Disease Control and Preve...
Notes from the Field: Shigella with Decreased Susceptibility to...
Notes from the Field: Shigella with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men - United States, 2002-2013 Bacteria of the genus Shigella cause approximately 500,000 illnesses each year in the United States.
Tue Feb 11, 2014
Furiex Pharma: What's The Best Plan Of Action?
In the last week, Furiex Pharmaceuticals soared 135% after its diarrhea drug proved statistically significant in two Phase 3 trials that enrolled 2,428 patients.